Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast cancer survival after trastuzumab ; volume:10 ; number:1 ; day:19 ; month:2 ; year:2024 ; pages:1-10 ; date:12.2024
npj Breast cancer ; 10, Heft 1 (19.2.2024), 1-10, 12.2024
- Creator
-
Meng, Pei
Dalal, Hina
Chen, Yilun
Brueffer, Christian
Gladchuk, Sergii
Alcaide, Miguel
Ehinger, Anna
Saal, Lao H.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41523-024-00621-x
- URN
-
urn:nbn:de:101:1-2404260709103.684923450529
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Meng, Pei
- Dalal, Hina
- Chen, Yilun
- Brueffer, Christian
- Gladchuk, Sergii
- Alcaide, Miguel
- Ehinger, Anna
- Saal, Lao H.
- SpringerLink (Online service)
Other Objects (12)
Cooperative antitumor activities of carnosic acid and Trastuzumab in ERBB2+ breast cancer cells
Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review
Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma
Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation
Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation
MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2-positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapy
Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer
Metastatic Salivary Duct Carcinoma with ERBB2 Amplification and Sequential Response to Ado-Trastuzumab Emtansine and Neratinib: A Case Report
Retraction Note to: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation
A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications
Cooperative antitumor activities of carnosic acid and Trastuzumab in ERBB2+ breast cancer cells
Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review
Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma
Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation
Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation
MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2-positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapy
Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer
Metastatic Salivary Duct Carcinoma with ERBB2 Amplification and Sequential Response to Ado-Trastuzumab Emtansine and Neratinib: A Case Report
Retraction Note to: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation
A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications
Cooperative antitumor activities of carnosic acid and Trastuzumab in ERBB2+ breast cancer cells
Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review
Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma
Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation
Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation
MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2-positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapy
Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer
Metastatic Salivary Duct Carcinoma with ERBB2 Amplification and Sequential Response to Ado-Trastuzumab Emtansine and Neratinib: A Case Report
Retraction Note to: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation